Search

A simple, noninvasive and cost-effective diagnostic test for the detection of endoleaks after endovascular aneurysm repair (EVAR) would complement (or even replace) current surveillance modalities. We reviewed the literature for studies correlating circulating levels of matrix metalloproteinases (MMPs)/tissue inhibitors of MMPs with the presence of endoleaks after EVAR. An electronic search of databases was performed to identify studies reporting circulating concentrations of MMPs in patients with and without an endoleak after EVAR. Four studies were identified. Patients with an endoleak had higher plasma MMP-9 levels compared with those without an endoleak. Two studies that also evaluated plasma MMP-3 levels after EVAR suggest that these levels may also be higher in patients with an endoleak. Preliminary evidence suggests that MMP-9 levels are increased in patients developing an endoleak after EVAR. Larger studies are required to confirm or refute our findings. [ABSTRACT FROM PUBLISHER]

Objective: To evaluate 2 different aortic endograft systems with suprarenal fixation in patients with unfavorable neck morphology. Methods: A prospective observational study assigning patients with abdominal aortic aneurysm with unfriendly neck anatomy treated with 2 different endograft systems (Endurant and Zenith) was conducted. The log-rank test was applied to investigate the differences in cumulative outcome parameters. Results: Successful endograft implantation was achieved in all patients. Requirement for troubleshooting techniques was similar in the 2 groups (P ¼ .156 and P ¼ .081, respectively). In-hospital procedure-related morbidity occurred in 7 patients (Zenith vs Endurant, P ¼ .690). Freedom from any type of endoleak and overall mortality did not differ significantly between the groups (log-rank test, P ¼ .068 and P ¼ .087). Reinterventions were more commonly required in the Zenith group (log-rank rest, P ¼ .041), and were all nongraft/aneurysm-related. Conclusions: Similar performances of the Zenith and the Endurant endograft systems were demonstrated. [ABSTRACT FROM AUTHOR]

Ten patients undergoing elective infrarenal aortic surgery were studied. Samples were taken perioperatively from a sigmoid tonometer to determine intramucosal pH (pHi) of the sigmoid colon, and simultaneously venous blood was taken for endotoxin measurement. Colonoscopy and biopsy were performed preoperatively and one week postoperatively. Significant endotoxemia was detected in 5 patients (50%), all of whom had transient colonic ischemia on the basis of tonometry, and of whom 2 had histologic evidence of ischemia at one week. Endotoxemia does occur during aortic surgery and appears to be associated with colonic ischemia, though this requires further evaluation. [ABSTRACT FROM PUBLISHER]

Endovascular repair of popliteal artery aneurysms is an emerging treatment in high risk surgical patients. The location in a functionally demanding anatomical area creates limitations in terms of endograft patency. Technological advancements have been conscripted in an effort to circumvent such constraints. The multilayer stent technology effects through haemodynamic modulation. We used the multilayer stent to treat 6 asymptomatic popliteal artery aneurysms in 3 patients. All procedures were successfully accomplished without any complications. Over a mean follow up period of 9 months, thrombosis occurred in two limbs, and blood flow was restored with thrombolysis, achieving a primary and secondary patency rate at 6 months of 67 % and 100 %, respectively. Partial or complete thrombosis of the aneurysm sac was achieved in all aneurysms. Even though the use of the multilayer stent in popliteal artery aneurysms was safe in the short term, our experience showed that close surveillance is required.